Leonard Bennett, Pharm.D

Serve as the primary point of clinical and HEOR contact for assigned key National Corporate Accounts and their enterprises, Integrated Health Networks (IHN's), and Government Accounts to support access to EMD Serono products. Develop and execute account-specific medical account management plans that is aligned with Medical Affairs and EMD Serono strategic objectives. Delivery of scientific and health economic key value messages to assigned customers. Act as a conduit between the external payer customer and the EMD Serono corporate NEVD and medical teams to ensure strategies and tactics are robust in filling key evidence gaps from a payer perspective. Assist to establish and maintain research and other collaborations with key external payer decision makers and influencers and EMD NEVD team. MOSL team lead for Mavenclad and previous bintrafusp alfa.

Directed clinical engagement efforts and developing/implementing medical account strategies on behalf of Novo Nordisk for Aetna & Humana national accounts. Previously assigned National Accounts were Cigna, Anthem, Express Scripts, Medco, and Catamaran (now United Health/Optum) along with priority regional accounts in Ohio, Kentucky, Michigan, West Virginia, Georgia, Florida and Puerto Rico. Provided evidence-based scientific information (proactive and reactive clinical and HEOR information) for Novo Nordisk products to executive formulary decision makers, thought leaders, and business influencers. Accountable for the development and maintenance of ongoing clinical relationships with business critical customers including C-suite individuals, Medical, Pharmacy, and Quality Directors, HEOR personnel, and other key clinical decision makers within strategic and priority Managed Markets accounts. Responsible for gathering customer insights regarding Novo Nordisk and compeititors' products to help inform internal medical and commercial teams.

Active member of Outcomes-Based Contracting core team and key participant in championing first Outcomes-Based contract within Novo Nordisk. Completed MASTER'S Program focused on semaglutide value-based contracting ideas and modeling and initiating early development of defining the function of the Value, Evidence, and Outcomes team.

Provided professional education and clinical data to Key Opinion Leaders (KOLs), clinicians, and other healthcare providers in Ohio, West Virginia, and Indiana.

Identified and cultivated long-term business relationships with clinical research stes and clinical research investigators. Identified and developed potential external clinicians/investigators for Amylin's professional speaker bureau to present scientific and clinical presentations of Amylin's products. Maintained clinical and scientific knowledge in the diabetes and obesity therapeutic areas by attending professional scientific meetings and partnering with Amylin's clinical, research, and commercial teams.

Field-Based Regional Medical Scientist that served as a liaison between GlaxoSmithKline and the Cardiovascular/Metabolic medical community in Ohio & West Virginia. Provided current professional education and research to Key Opinion Leaders, clinicians,other healthcare providers, and managed care accounts in Ohio & West Virginia. Developed potential external clinicians/investigators as speakers for the company on scientific and clinical benefits of GSK products.

Maintained clinical and scientific knowledge in the diabetes and osteoporosis therapeutic areas by attending professional scientific meetings and partnering with GSK's clinical, research, and commercial teams.

Served as a liaison between the Prescription Benefit Management company, Managed Care clients, and Healthcare Providers to drive appropriate and economical health outcomes. Focused on interactions with Family Practice, Internal Medicine, Cardiology, Gastroenterology, Endocrinology, Ophthalmology, and Psychiatry physicians. Proactively engaged in clinical discussions to increase utilization of targeted pharmaceuticals products on the PBM National Preferred Drug Formulary. Worked with Director of Pharmacy from Managed Care clients in Southern Georgia and Northern Florida to give guidance to changes in the Preferred Drug Formulary and assisted in problem solving and resolution between physicians and health plans.

Responsible for operations, personnel, and financials for pharmaceutical business with included retail pharmacy, durable medical equipment (DME), and infusion center that supplied medications, supplies and services to patients of First American Home Health (large privately home health care company in US). Managed 35 people including pharmacist, technicians, billing department, accounting and delivery people in 3 different sites of business. Responsible for negotiating contract in all sectors of business including retail pharmacy, durable medical equipment, enteral nutritional products, and infusion center contracts from payers and ensuring compliance and proper reimbursement for all contracts.

District Pharmacy Manager for 17 pharmacy departments located in Georgia and Alabama. Responsibility included personnel management for 45 pharmacist and 240 pharmacy associates. Responsible for financial management of P& L statements for entire pharmacy district with sales of over $30 million dollars. Previous role was Pharmacy Manager at Wal*Mart Pharmacy, Jacksonville, FL. This pharmacy had 6th highest prescription volume within Wal*Mart company.